KDIGO 2024, the four pillars, and the FLOW & CONFIDENCE trials — what primary care needs to do differently for chronic kidney disease.
Chronic Kidney Disease in Primary Care: The Four Pillars of Kidney Protection Read More »
The 2026 ADA Standards of Care and AACE Type 2 Diabetes Algorithm: earlier CGM, comorbidity-first therapy, and weight targets every clinician should know.
Diabetes Guidelines 2026: The ADA and AACE Updates Every Clinician Needs Read More »
For the first time in eight years, the American Heart Association (AHA) and the American College of Cardiology (ACC) have released a comprehensive overhaul of their hypertension guidelines. The 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults arrives at a critical moment: hypertension remains the single most
2025 AHA/ACC Hypertension Guidelines: What Every Primary Care Clinician Must Know Read More »
The Global Initiative for Asthma (GINA) released its 2026 Strategy Report on May 5, 2026, and primary care is squarely in its crosshairs. Asthma affects roughly 25 million Americans, and the majority of routine management still happens in family medicine, internal medicine, and advanced-practice offices rather than in pulmonology subspecialty suites. The 2026 update reflects
GINA 2026: What’s New in Asthma Management for Primary Care Read More »
For years, the conversation around GLP-1 receptor agonists in type 2 diabetes centered almost entirely on glucose lowering. Then came a series of landmark cardiovascular outcomes trials — LEADER, SUSTAIN-6, PIONEER 6 — and the paradigm began to shift. But until recently, one practical barrier remained: most GLP-1 receptor agonists required subcutaneous injection, limiting uptake
Heart failure with preserved ejection fraction (HFpEF) now accounts for more than half of all heart failure diagnoses in the United States, and the proportion continues to rise alongside the obesity epidemic. For decades, clinicians managing this phenotype had few effective pharmacologic tools — spironolactone and SGLT-2 inhibitors offered modest benefit in selected patients, but
If you’re a physician, nurse practitioner, or physician assistant attending continuing medical education conferences or completing online CME courses, you may be leaving money on the table at tax time. CME expenses are among the most legitimate — and most overlooked — tax deductions available to healthcare professionals. This guide breaks down exactly what qualifies
CME Tax Deduction Guide for Physicians in 2026: What You Can (and Can’t) Deduct Read More »
The San Diego May 2026 conference has concluded — San Diego 2027 waitlist is open. San Diego isn’t just a premier destination for professional education — it’s also one of the most vibrant cities in the U.S. for sightseeing, dining, and entertainment. If you attended the San Diego CME Conference, May 1–2, 2026, at the
Top Things to Do in San Diego While Attending CME Read More »
Cardiovascular disease remains the leading cause of death worldwide, and aggressive lipid management remains one of the most effective ways to reduce risk. The latest ACC/AHA dyslipidemia guideline updates (released March 2026) reinforce aggressive LDL-C reduction, emphasize earlier risk assessment, and expand the role of non-statin therapies. For busy clinicians in primary care, cardiology, and
ACC/AHA Dyslipidemia Guidelines 2026: Top 10 Updates Clinicians Must Know Read More »
Primary care clinicians face an increasingly complex landscape in chronic disease management. With evolving guidelines, new medications, and technology-driven care models, staying current is essential—not only to improve patient outcomes but also to meet continuing medical education (CME) requirements efficiently. Here are five critical updates in chronic disease management that every primary care clinician should
Top 5 Chronic Disease Management Updates for Primary Care Clinicians in 2026 Read More »
